Corona and Parley for the Oceans partner with Stephanie Gilmore, Gabriel Medina and artists to support the ban of single-use plastic in Bali and provide households with reusable alternatives.
14.5.2019 10:00:00 EEST | Business Wire | Press release
It is estimated that roughly 5 trillion plastic bags are consumed worldwide each year1 with as many as 10 million plastic bags entering circulation in Indonesia every day2. Earlier this year, Bali announced a ban of all single-use plastic (including plastic bags) that takes affect later this year. For the first time, Balinese would have to rely on reusable bags exclusively.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190514005361/en/
Corona's La Casa pop-up space, made from 1.5 tons of recycled plastic. (Photo: Business Wire)
To help support the local NGOs who have been leading the charge against single-use plastic and as part of their commitment to the region where the annual Bali Pro-tected surf event takes place, Corona, Parley and World Surf League are donating 20,000 reusable bags made from Ocean Plastic®. Limited edition bags are also being created on-site and will be sold in real-time at wslstore.com. The proceeds from each bag purchased funds the donation of an additional 3 bags to the local community and the removal of more than 20 bottles worth of plastic. The ambition over time is to provide one bag for every household in Indonesia.
The limited-edition bags were designed by Stephanie Gilmore, Gabriel Medina and Rosy Hodge in partnership with artists Nadia Hernandez, Speto and Gemma O’Brien respectively. Surfers on the WSL Championship Tour have also shown their support by designing their own bags to raise awareness of the project. The collaborators are part of the inaugural “La Casa” pop-up, a house made from 1.5 tons of recycled plastic in partnership with NevHouse. Founded by Corona, the house will become a platform for surfers, artists and thought-leaders to work on projects that can inspire a better world. The house itself is a positive reminder that plastic can be given a meaningful second life, much like the bags. Each pop-up will include new collaborators and new projects to help protect paradise from plastic pollution.
“The La Casa platform is about collaboration and creativity to energize the fight against marine plastic pollution,” said Evan Ellman, Corona Better World Director. “In this case, Corona and our partners Parley and World Surf League, were inspired by the movement to ban single-use plastic in Bali and recognized an opportunity to support the transition. Just as impressive are the talented collaborators who signed on to bring their voice and point of view to the project. The result is a product that is not only a symbol of change, but also has a significant impact on the environment and community.”
La Casa is the latest initiative from Corona and Parley for the Oceans who have a mutual mission to protect the world’s oceans and beaches. To date, the partnership has engaged in 100 islands around the world through a clean-up network present in over 23 countries, resulting in 537 clean-ups, 25,000 volunteers and more than 3 million square meters of beach cleaned. This includes Corona’s support of Parley’s strategy to end marine plastic pollution: A.I.R. (Avoid, Intercept and Redesign). Most recently, Corona and Parley partnered with Oscar-nominated stop-motion artist PES to create a film on Earth Day raising awareness that “avoiding” and “intercepting” plastic saves the lives of marine wildlife. The La Casa initiative in Bali is an example of how that plastic can be “redesigned” into a product that replaces single-use plastic.
La Casa Corona will be at the Corona Bali Pro-tected event in Keramas, Bali, Indonesia from May 13 - May 25, 2019. To learn more and purchase a bag visit wslstore.com.
-###-
ABOUT CORONA
Born in Mexico, Corona is the leading beer brand in the country, the most popular Mexican beer worldwide exported to more than 180 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City. Corona is a pioneer in the beer industry by being the first to use a transparent bottle showcasing its purity and high quality to the world. The artwork found on the bottle is painted, highlighting our commitment to quality in our packaging and our Mexican heritage. No Corona is complete without the lime. Naturally adding character, flavor and refreshment, the lime ritual is an integral part of delivering an experience that is truly unique to Corona. The brand is synonymous with the beach and celebrates time outdoors. It invites people to pause, relax and enjoy the simple pleasures of life.
ABOUT PARLEY FOR THE OCEANS
Parley for the Oceans is the global network where creators, thinkers and leaders from the creative industries, brands, governments and environmental groups come together to raise awareness for the beauty and fragility of the oceans and collaborate on projects that can end their destruction. The organization has formed alliances with major corporations including adidas, Anheuser Busch InBev (Corona), American Express; the United Nations; the Maldives and collaborators spanning the worlds of science, art, fashion, design, entertainment, sports, and space and ocean exploration. To know more: www.parley.tv
ABOUT THE WSL
The World Surf League (WSL) is the global home of surfing, dedicated to celebrating the world's best surfing on the world's best waves. The WSL has been championing the world's best surfing since 1976, annually running more than 180 global events across the Men's and Women's Championship Tours, the Big Wave Tour, the Longboard Tour, Qualifying Series, Pro Junior Tour, as well as the WSL Big Wave Awards. The League possesses a deep appreciation for the sport's rich heritage while promoting progression, innovation, and performance at the highest levels, and in doing so crowns the undisputed Men’s and Women’s World Champions across all tours. For more information, please visit WorldSurfLeague.com.
1
https://wedocs.unep.org/bitstream/handle/20.500.11822/25513/state_plastics_WED.pdf?isAllowed=y&sequence=1
2
https://www.theinertia.com/environment/indonesia-pledges-1-billion-a-year-to-reduce-its-ocean-waste/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190514005361/en/
Contact information
Alison Brod Marketing + Communications:
Corona@alisonbrodmc.com
212-230-1800
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom